Apathy

• CLINICAL_TRIALS trial_result · 2026-07-10
  Clinical Trial Results: Accelerated rTMS for Post-Stroke Apathy [Phase 1]

  Phase 1 trial results for accelerated repetitive transcranial magnetic stimulation (rTMS) as a treatment for post-stroke apathy have been co…

• CLINICAL_TRIALS trial_result · 2025-06-12
  Clinical Trial Update: Accelerated rTMS for Post-Stroke Apathy [Phase 1]

  A Phase 1 trial evaluating accelerated repetitive transcranial magnetic stimulation (rTMS) for post-stroke apathy has completed.

• CLINICAL_TRIALS trial_result · 2023-06-13
  Clinical Trial Update: Apathy in Dementia Methylphenidate Trial 2 [Phase 3]

  Phase 3 clinical trial on methylphenidate for apathy in Alzheimer's disease completed with results posted.

• CLINICAL_TRIALS trial_result · 2021-06-01
  Clinical Trial Update: In Vivo Involvement of the Cholinergic and Dopaminergic Systems in the Pathophysiology of Apathy. [Phase 3]

  A Phase 3 clinical trial investigates the role of cholinergic and dopaminergic systems in the pathophysiology of apathy, with status current…

• CLINICAL_TRIALS trial_result · 2019-10-04
  Clinical Trial Update: Role of Apathy in the Effectiveness of Weight Loss Interventions [NA]

  Completed clinical trial evaluating how apathy affects the effectiveness of weight loss interventions.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2019-08-21
  Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's Dementia [Phase 4]

  Phase 4 trial update on repetitive transcranial magnetic stimulation for apathy in Alzheimer's dementia has completed.

• CLINICAL_TRIALS trial_result · 2017-07-06
  Clinical Trial Update: Apathy in Tourette Syndrome and Changes in Quality of Life

  A clinical trial evaluating apathy in individuals with Tourette syndrome and its impact on quality of life has completed.

• CLINICAL_TRIALS trial_result · 2013-01-10
  Clinical Trial Update: Evaluation of the Efficacy of Rasagiline in Apathy in Drug-naïve Patients With Parkinson's Disease by a Multi-center Study [Phase 4]

  A multi-center Phase 4 trial is evaluating the efficacy of rasagiline for apathy in drug-naïve patients with Parkinson's disease.